Annual Total Expenses
$15.28 M
-$3.70 M-19.49%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual total expenses is $15.28 million, with the most recent change of -$3.70 million (-19.49%) on December 1, 2023.
- During the last 3 years, BRTX annual total expenses has risen by +$12.45 million (+440.21%).
- BRTX annual total expenses is now -42.01% below its all-time high of $26.35 million, reached on December 31, 2021.
Performance
BRTX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$2.52 M
-$37.30 K-1.46%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly total expenses is $2.52 million, with the most recent change of -$37.30 thousand (-1.46%) on September 1, 2024.
- Over the past year, BRTX quarterly total expenses has dropped by -$531.20 thousand (-17.41%).
- BRTX quarterly total expenses is now -83.28% below its all-time high of $15.07 million, reached on March 31, 2021.
Performance
BRTX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
BRTX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.5% | -17.4% |
| 3 y3 years | +440.2% | -37.2% |
| 5 y5 years | +97.0% | -37.2% |
BRTX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.0% | at low | -56.6% | at low |
| 5 y | 5-year | -42.0% | +440.2% | -83.3% | +424.5% |
| alltime | all time | -42.0% | +638.6% | -83.3% | +580.9% |
BioRestorative Therapies Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.52 M(-1.5%) |
| Jun 2024 | - | $2.56 M(-38.3%) |
| Mar 2024 | - | $4.14 M(+27.9%) |
| Dec 2023 | $15.28 M(-19.5%) | $3.24 M(+6.2%) |
| Sep 2023 | - | $3.05 M(-4.1%) |
| Jun 2023 | - | $3.18 M(-45.3%) |
| Mar 2023 | - | $5.81 M(+26.5%) |
| Dec 2022 | $18.98 M(-28.0%) | $4.59 M(-1.0%) |
| Sep 2022 | - | $4.64 M(-1.3%) |
| Jun 2022 | - | $4.70 M(-7.0%) |
| Mar 2022 | - | $5.05 M(+25.9%) |
| Dec 2021 | $26.35 M(+831.5%) | $4.01 M(+8.6%) |
| Sep 2021 | - | $3.70 M(+3.5%) |
| Jun 2021 | - | $3.57 M(-76.3%) |
| Mar 2021 | - | $15.07 M(+1629.5%) |
| Dec 2020 | $2.83 M(-67.0%) | $871.50 K(+39.4%) |
| Sep 2020 | - | $625.30 K(+30.1%) |
| Jun 2020 | - | $480.60 K(-43.1%) |
| Mar 2020 | - | $845.00 K(-61.4%) |
| Dec 2019 | $8.56 M(+10.4%) | $2.19 M(+17.8%) |
| Sep 2019 | - | $1.86 M(-14.0%) |
| Jun 2019 | - | $2.16 M(-8.4%) |
| Mar 2019 | - | $2.36 M(+6.8%) |
| Dec 2018 | $7.76 M(-8.2%) | $2.21 M(+81.7%) |
| Sep 2018 | - | $1.21 M(-41.8%) |
| Jun 2018 | - | $2.09 M(-7.2%) |
| Mar 2018 | - | $2.25 M(+39.7%) |
| Dec 2017 | $8.46 M | $1.61 M(-8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $1.76 M(-32.0%) |
| Jun 2017 | - | $2.59 M(+3.7%) |
| Mar 2017 | - | $2.50 M(+33.8%) |
| Dec 2016 | $7.82 M(+0.3%) | $1.87 M(+8.5%) |
| Sep 2016 | - | $1.72 M(-20.3%) |
| Jun 2016 | - | $2.16 M(+4.0%) |
| Mar 2016 | - | $2.08 M(-30.6%) |
| Dec 2015 | $7.80 M(+46.1%) | $2.99 M(+88.6%) |
| Sep 2015 | - | $1.59 M(+12.4%) |
| Jun 2015 | - | $1.41 M(-22.0%) |
| Mar 2015 | - | $1.81 M(+29.7%) |
| Dec 2014 | $5.34 M(+12.3%) | $1.40 M(+32.2%) |
| Sep 2014 | - | $1.06 M(-27.5%) |
| Jun 2014 | - | $1.46 M(+2.0%) |
| Mar 2014 | - | $1.43 M(+18.1%) |
| Dec 2013 | $4.75 M(-14.9%) | $1.21 M(+7.1%) |
| Sep 2013 | - | $1.13 M(+1.3%) |
| Jun 2013 | - | $1.11 M(-14.3%) |
| Mar 2013 | - | $1.30 M(-23.7%) |
| Dec 2012 | $5.59 M(+57.3%) | $1.70 M(+40.8%) |
| Sep 2012 | - | $1.21 M(-10.3%) |
| Jun 2012 | - | $1.35 M(+1.9%) |
| Mar 2012 | - | $1.32 M(+105.9%) |
| Dec 2011 | $3.55 M(+71.7%) | $643.20 K(-24.6%) |
| Sep 2011 | - | $853.00 K(-17.8%) |
| Jun 2011 | - | $1.04 M(+2.0%) |
| Mar 2011 | - | $1.02 M(-13.5%) |
| Dec 2010 | $2.07 M | $1.18 M(+217.8%) |
| Sep 2010 | - | $370.20 K |
FAQ
- What is BioRestorative Therapies annual total expenses?
- What is the all time high annual total expenses for BioRestorative Therapies?
- What is BioRestorative Therapies annual total expenses year-on-year change?
- What is BioRestorative Therapies quarterly total expenses?
- What is the all time high quarterly total expenses for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly total expenses year-on-year change?
What is BioRestorative Therapies annual total expenses?
The current annual total expenses of BRTX is $15.28 M
What is the all time high annual total expenses for BioRestorative Therapies?
BioRestorative Therapies all-time high annual total expenses is $26.35 M
What is BioRestorative Therapies annual total expenses year-on-year change?
Over the past year, BRTX annual total expenses has changed by -$3.70 M (-19.49%)
What is BioRestorative Therapies quarterly total expenses?
The current quarterly total expenses of BRTX is $2.52 M
What is the all time high quarterly total expenses for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly total expenses is $15.07 M
What is BioRestorative Therapies quarterly total expenses year-on-year change?
Over the past year, BRTX quarterly total expenses has changed by -$531.20 K (-17.41%)